Effectiveness of erdosteine, a second generation mucolytic agent, in children with acute rhinosinusitis: a randomized, placebo controlled, double‐blinded clinical study

Abstract

Use of erdosteine as a mucolytic agent in children with acute rhinosinusitis does not directly affect the success of treatment.